InvestLog
APLS Apellis Pharmaceuticals, Inc. logo

APLS Apellis Pharmaceuticals, Inc.

Healthcare
$41.03+0.00%ClosedMarket Cap: $5.25B

As of 2026-05-25

Insider Statistics (Q2 2026)

Acquisitions

36

Dispositions

144

Buy/Sell Ratio

0.25

Net Shares

-7,082,032

Shares Acquired

1,411,957

Shares Disposed

8,493,989

Total Bought ($)

$0.00

Total Sold ($)

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Thu May 14Dunlop A. SinclairdirectorSell161,567$4.000
Thu May 14Dunlop A. SinclairdirectorSell27,600$30.620
Thu May 14Dunlop A. SinclairdirectorSell14,684$25.120
Thu May 14Dunlop A. SinclairdirectorSell11,199$31.910
Thu May 14Dunlop A. SinclairdirectorSell8,554$47.280
Thu May 14Dunlop A. SinclairdirectorSell7,441$51.710
Thu May 14Dunlop A. SinclairdirectorSell5,748$59.860
Thu May 14Dunlop A. SinclairdirectorSell3,544$0.000
Thu May 14Chopas James Georgeofficer: VP/Chief Accounting OfficerSell16,150$0.0016,150
Fri May 01Baumal Carolineofficer: Chief Medical OfficerSell900$0.0086,525
Mon Apr 20Sullivan Timothy Eugeneofficer: Chief Financial OfficerSell11,096$0.00140,945
Wed Apr 08O'Brien Stephanie MonaghandirectorSell5,750$0.005,750
Mon Apr 06BIOGEN INC.other: See footnotesSell0$0.000
Fri Mar 13Francois Cedricdirector, officer: Chief Executive OfficerSell64,869$0.00425,968
Tue Mar 03Dolsten MikaeldirectorSell24,135$20.9624,135